Novel approaches to developing new antibiotics for bacterial infections.
about
Bioprospecting Sponge-Associated Microbes for Antimicrobial CompoundsAcinetobacter baumannii: an emerging opportunistic pathogenDesign of O -Acetylserine Sulfhydrylase Inhibitors by Mimicking NatureA new approach for the discovery of antibiotics by targeting non-multiplying bacteria: a novel topical antibiotic for staphylococcal infectionsBioprospecting microbial natural product libraries from the marine environment for drug discovery.Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.Classification of 17 newly isolated virulent bacteriophages of Pseudomonas aeruginosa.Identification of In Vitro Metabolites of Amoxicillin in Human Liver Microsomes by LC-ESI/MS.The enzymes of β-lactam biosynthesis.A survey of medicinal plants used by Kavirajes of Chalna area, Khulna district, Bangladesh.PHAST: a fast phage search tool.Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.Inhibition of the dapE-Encoded N-Succinyl-L,L-diaminopimelic Acid Desuccinylase from Neisseria meningitidis by L-Captopril.New trends in pharmacogenomic strategies against resistance development in microbial infections.Dual colorimetric and luminescent assay for dipicolinate, a biomarker of bacterial spores.In vitro antibacterial activity of Tabernaemontana alternifolia (Roxb) stem bark aqueous extracts against clinical isolates of methicillin resistant Staphylococcus aureus.Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.Potential probiotic-associated traits revealed from completed high quality genome sequence of Lactobacillus fermentum 3872.Microbial Biofilms and Chronic WoundsTargeting the "cytokine storm" for therapeutic benefit.Significance and biological importance of pyrimidine in the microbial world.Utility of the Biosynthetic Folate Pathway for Targets in Antimicrobial Discovery.Selective killing of nonreplicating mycobacteria.Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.Novel antibiotics for the treatment of Staphylococcus aureus.Comparative Analysis of the Flavobacterium columnare Genomovar I and II Genomes.In vivo growth rates are poorly correlated with phage therapy success in a mouse infection model.Novel Role for PilNO in Type IV Pilus Retraction Revealed by Alignment Subcomplex MutationsA Molecular Docking and Dynamics Study to Screen Potent Anti-Staphylococcal Compounds Against Ceftaroline Resistant MRSA.In Vitro Antibacterial, Antifungal, Antibiofilm, Antioxidant, and Anticancer Properties of Isosteviol Isolated from Endangered Medicinal Plant Pittosporum tetraspermum.Novel pentadecenyl tetrazole enhances susceptibility of methicillin-resistant Staphylococcus aureus biofilms to gentamicin.antibacTR: dynamic antibacterial-drug-target ranking integrating comparative genomics, structural analysis and experimental annotation.Silver Nanoparticles: Biosynthesis Using an ATCC Reference Strain of Pseudomonas aeruginosa and Activity as Broad Spectrum Clinical Antibacterial Agents.Streptomyces sp. AT37 isolated from a Saharan soil produces a furanone derivative active against multidrug-resistant Staphylococcus aureus.Artonin I inhibits multidrug resistance in Staphylococcus aureus and potentiates the action of inactive antibiotics in vitro.A novel bacteriocin from Enterococcus faecalis 478 exhibits a potent activity against vancomycin-resistant enterococci.Mugs of the bugs: The most wanted ones.
P2860
Q26752805-AFAC0D42-439F-43B2-AB91-4EE223BE11CBQ26830893-A16D1E82-9464-4C77-BCE8-A751261D44BDQ27658287-6323527C-F6A5-42EE-AF58-4E644431B67AQ28474929-2D655CD3-B4A1-4C1B-B9E7-BCC9F100B211Q30985377-7BB0C7FD-FD16-4C88-8BA7-5B16D975BA7DQ33567388-2C836711-7A21-48D7-85E0-EEAE0F868C13Q33746414-3F8D4B7E-322B-46EC-83A1-4B70DB21AE91Q33953636-7D734095-64B6-44BD-B8CB-B5EDB2E4258FQ34310470-77EE4A7F-230C-4A9F-B5ED-BFAE2647717EQ34491265-D6C4BA31-6DBC-440B-A013-9908B44DD1DFQ35075734-CDF0D1C6-6CC6-4010-B272-3F3FA674C830Q35542339-78B0B203-D448-42D6-BB1F-9697968FFEB1Q35853204-1917EAC7-7FBB-4D39-B4A3-2CDD40BA5421Q36012460-FED4F8DF-3D49-47C6-9482-0268B9AAB08AQ36350977-91DC50BC-9A31-4A27-9213-F92B5F55326EQ37329167-1682BB43-05A3-4074-BD91-09D6CB545EF0Q37344056-8C10FCB4-F6D1-4B52-8734-E1AFB315731DQ37364281-3EF63F7A-6905-4C9B-AA1C-7D22F32AAF2FQ37521070-A519FACF-A0EE-4911-AC1D-ABFAABEFCF7EQ37618438-2674AFE9-A47E-47DB-A3F4-0AB44D37A4CCQ37731248-32797550-7881-405D-A9E4-DF2638CA8479Q38071254-6E54F78F-FD53-464C-8A27-62938318B79AQ38266477-035A56A7-3285-47DC-8F82-0510D12495EBQ38792855-CA368183-5B6A-41DF-9D36-A45A1C64ACC9Q39038658-06900636-6A9A-4A9C-9E2D-326DDF564EF6Q39432050-49EB5BF1-C913-4229-93B4-D29D29E2493FQ39747962-C444473D-126F-4A05-B370-7680A19C5906Q39933945-B18D9BC0-A41B-4A30-914E-FC6F4B578B02Q40101240-58E57626-9B23-4CF4-A810-653CE7CA577DQ40601668-F57DCFE3-CAF2-4DEA-AFDA-17C648BA626EQ41007265-207F933F-69A4-4E56-B05E-51F95FCE84E9Q41064686-BAAECFEF-CE7A-4FB5-B063-C84A0A933023Q41144925-263FB98D-9920-41D4-8BCE-DA5D68797D7EQ41824636-FB1565F1-AEB5-4E3C-86B9-7EEC4A410955Q41974129-59B1B935-355A-4AAB-949E-972E79C528D5Q42725309-D9C9CAE3-D9CC-4F87-9381-6150E259EA6BQ46372762-9A4AD3AD-2332-4CD5-B6B6-E5F11164826CQ46870346-BF875CD0-24C4-426A-9E98-1063C286DA20Q47115953-2B4E6970-98D4-4187-8050-B53E99115C3CQ48271598-982616D0-171F-415B-B0B1-B82E2A531CE0
P2860
Novel approaches to developing new antibiotics for bacterial infections.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Novel approaches to developing new antibiotics for bacterial infections.
@ast
Novel approaches to developing new antibiotics for bacterial infections.
@en
type
label
Novel approaches to developing new antibiotics for bacterial infections.
@ast
Novel approaches to developing new antibiotics for bacterial infections.
@en
prefLabel
Novel approaches to developing new antibiotics for bacterial infections.
@ast
Novel approaches to developing new antibiotics for bacterial infections.
@en
P2860
P356
P1476
Novel approaches to developing new antibiotics for bacterial infections.
@en
P2093
P2860
P304
P356
10.1038/SJ.BJP.0707432
P407
P577
2007-08-20T00:00:00Z